Search

Genmab A-S

Открыт

2,033 2.19

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

1973

Макс.

2012

Ключевые показатели

By Trading Economics

Доход

243M

295M

Продажи

259M

1.2B

P/E

Средняя по отрасли

24.245

57.002

Прибыль на акцию

34.85

Рентабельность продаж

25.541

Сотрудники

3,119

EBITDA

216M

431M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-1.49% downside

Дивиденды

By Acuity

Следующий отчет о доходах

5 нояб. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

11B

124B

Предыдущая цена открытия

2030.81

Предыдущая цена закрытия

2033

Genmab A-S График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

11 авг. 2026 г., 23:56 UTC

Coherent Corp shares are higher in after-market trading, continuing a strong upward trend since Tuesday's close amid broader market volatility and fluctuating oil prices.

11 авг. 2026 г., 23:56 UTC

Paychex Inc. shares are higher in after-market trading, maintaining a position above its 20-day moving average amid recent volatility in Brent crude oil prices.

11 авг. 2026 г., 23:56 UTC

Arcos Dorados Holdings shares are higher in after-market trading, despite five consecutive lower sessions. Market volatility is influenced by rising Brent crude oil prices.

11 авг. 2026 г., 23:56 UTC

Citizens Financial Group Inc shares are higher in after-hours trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 авг. 2026 г., 23:56 UTC

News

GrowGeneration reports second-quarter net sales of $43.2 million, a 5.5% increase. Shares are higher in after-market trading following the earnings announcement.

11 авг. 2026 г., 23:56 UTC

Assurant Inc. shares rose after-market, recovering from an early dip amid broader market volatility linked to Brent crude oil fluctuations and investor caution ahead of CPI data.

11 авг. 2026 г., 23:56 UTC

News

Digital Realty Trust announced a quarterly dividend of $1.22 per share. Shares are trading higher in after-market hours following the announcement.

11 авг. 2026 г., 23:56 UTC

Macy's Inc. shares are higher in after-market hours, driven by notable strength in the Broadline Retail sub-sector, despite no specific company news identified.

11 авг. 2026 г., 23:56 UTC

Monro Inc shares are trading higher in after-market hours amid broader market volatility and rising Brent crude oil prices above $90 per barrel.

11 авг. 2026 г., 23:56 UTC

Social Media

Twilio Inc shares are higher in after-market hours, supported by social media discussions on a "massive stage 1 base breakout" and increased full-year guidance.

11 авг. 2026 г., 23:56 UTC

Kaiser Aluminum Corp shares are higher in after-market trading. The stock remains above its 20-day moving average amid broader market volatility.

11 авг. 2026 г., 23:56 UTC

Alibaba Group Holding Ltd shares are higher in after-market trading, reflecting routine performance within a narrow range above the 20-day moving average.

11 авг. 2026 г., 23:56 UTC

CH Robinson Worldwide shares are trading higher in after-market hours, reflecting some resilience amid broader market volatility and fluctuating Brent crude oil prices.

11 авг. 2026 г., 23:56 UTC

Fluence Energy Inc shares are higher in after-market hours, trading within a narrow range. No specific news was identified to explain the movement.

11 авг. 2026 г., 23:56 UTC

Chemours Co shares are higher in after-market trading, reflecting notable activity since Tuesday's close. The stock remains below its 20-day moving average.

11 авг. 2026 г., 23:56 UTC

Genco Shipping & Trading Ltd shares are higher in after-market trading, rising from session lows despite being below its 20-day moving average and near a one-month low.

11 авг. 2026 г., 23:56 UTC

Broadridge Financial Solutions Inc shares are higher in after-market trading, recovering from a session dip and remaining above the 20-day moving average.

11 авг. 2026 г., 23:56 UTC

News

UBS maintains Buy rating on Rapid7 and raises price target to $12. Shares are trading higher in after-market hours, reflecting positive investor sentiment.

11 авг. 2026 г., 23:56 UTC

Kraft Heinz Co shares are trading slightly higher in after-market hours. No specific news was identified to explain this movement.

11 авг. 2026 г., 23:56 UTC

PennyMac Mortgage Investment Trust shares are higher in after-market trading, reflecting a slight uptick amid broader market volatility. No specific news was identified.

11 авг. 2026 г., 23:56 UTC

Correlated Moves

American Water Works Company reported no specific news after-market hours. The stock was roughly flat, reflecting broader market sentiment and stability.

11 авг. 2026 г., 23:56 UTC

Atmos Energy Corp shares are trading higher in after-market hours. This movement occurs amid broader market volatility and fluctuating Brent crude oil prices.

11 авг. 2026 г., 23:56 UTC

Axon Enterprise Inc. shares are lower in after-market trading, despite a recent trend of three consecutive higher daily closes.

11 авг. 2026 г., 23:52 UTC

ETF Constituents
Correlated Moves
Macro News

iShares MSCI South Korea ETF rises in after-market trading, supported by technology stock gains and broader equity market movements. It remains above its 20-day moving average.

11 авг. 2026 г., 23:52 UTC

Monster Beverage Corp. shares rose during after-market hours, recovering from a slight pullback. Market focus remains on upcoming economic data, including the CPI report.

11 авг. 2026 г., 23:52 UTC

Social Media

Entravision Communications Corp shares are rising in after-market trading amid positive investor sentiment and discussions of potential favorable price movements.

11 авг. 2026 г., 23:52 UTC

Correlated Moves

Booking Holdings Inc shares are lower in after-market hours amid broader market declines. Investors await the upcoming consumer price index report for further guidance.

11 авг. 2026 г., 23:51 UTC

Xpeng Inc. shares were roughly flat in after-market trading. Market attention remains on the upcoming consumer price index report amid recent job loss data.

11 авг. 2026 г., 23:51 UTC

Correlated Moves

Cohu Inc. shares are lower in after-market trading, influenced by a slight decline in the Nasdaq 100 Index and overall market sentiment.

11 авг. 2026 г., 23:51 UTC

Eton Pharmaceuticals Inc shares are lower in after-market trading amid unusual volatility. No specific news was identified to explain the decline.

Сравнение c конкурентами

Изменение цены

Genmab A-S Прогноз

Целевая цена

By TipRanks

-1.49% падение

Прогноз на 12 месяцев

Средняя 2,493.35 DKK  -1.49%

Максимум 3,320 DKK

Минимум 308.417 DKK

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для Genmab A-S на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

7 ratings

3

Покупка

2

Удержание

2

Продажа

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Genmab A-S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.
help-icon Live chat